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The bonemarrow (BM) exists heterogeneously as hematopoietic/red or adipocytic/yellow
marrow depending on skeletal location, age, and physiological condition. Mouse models
and patients undergoing radio/chemotherapy or suffering acute BM failure endure rapid
adipocytic conversion of the marrow microenvironment, the so-called “red-to-yellow”
transition. Following hematopoietic recovery, such as upon BM transplantation, a
“yellow-to-red” transition occurs and functional hematopoiesis is restored. Gold
Standards to estimate BM cellular composition are pathologists’ assessment of
hematopoietic cellularity in hematoxylin and eosin (H&E) stained histological sections
as well as volumetric measurements of marrow adiposity with contrast-enhanced
micro-computerized tomography (CE-µCT) upon osmium-tetroxide lipid staining. Due
to user-dependent variables, reproducibility in longitudinal studies is a challenge for both
methods. Here we report the development of a semi-automated image analysis plug-in,
MarrowQuant, which employs the open-source software QuPath, to systematically
quantify multiple bone components in H&E sections in an unbiased manner.
MarrowQuant discerns and quantifies the areas occupied by bone, adipocyte ghosts,
hematopoietic cells, and the interstitial/microvascular compartment. A separate feature,
AdipoQuant, fragments adipocyte ghosts in H&E-stained sections of extramedullary
adipose tissue to render adipocyte area and size distribution. Quantification of BM
hematopoietic cellularity with MarrowQuant lies within the range of scoring by four
independent pathologists, while quantification of the total adipocyte area in whole
bone sections compares with volumetric measurements. Employing our tool, we were
able to develop a standardized map of BM hematopoietic cellularity and adiposity
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in mid-sections of murine C57BL/6 bones in homeostatic conditions, including
quantification of the highly predictable red-to-yellow transitions in the proximal section
of the caudal tail and in the proximal-to-distal tibia. Additionally, we present a
comparative skeletal map induced by lethal irradiation, with longitudinal quantification
of the “red-to-yellow-to-red” transition over 2 months in C57BL/6 femurs and tibiae. We
find that, following BM transplantation, BM adiposity inversely correlates with kinetics
of hematopoietic recovery and that a proximal to distal gradient is conserved. Analysis
of in vivo recovery through magnetic resonance imaging (MRI) reveals comparable
kinetics. On human trephine biopsies MarrowQuant successfully recognizes the BM
compartments, opening avenues for its application in experimental, or clinical contexts
that require standardized human BM evaluation.
Keywords: bone marrow, hematoxylin and eosin, histology, adipocyte, pathology, skeleton, cellularity,
hematopoietic
INTRODUCTION
Bone marrow adipocytes (BMAds) were long considered as
passive fillers of the marrow cavity. In recent years, they have
become accepted as occupying an important role within the bone
marrow (BM) microenvironment in health and disease, while
also contributing to whole-body energy homeostasis (1, 2).
At birth, the murine and human skeleton is entirely
hematopoietic. BMAds appear shortly thereafter and increase
throughout juvenile development in a centripetal fashion as
the skeleton matures (3). This reciprocal relationship between
adipocytic and hematopoietic content has been known since
the enunciation of the “Neumann” law in 1902, describing the
age-driven adipocytic conversion of the marrow in distal bones.
Indeed, due to the macroscopic coloration of the predominant
cell types, the marrow has been broadly categorized as
hematopoietic/red or adipocytic/yellow marrow (4). In humans,
adipocytes become the most abundant cellular component in the
adult BM. In mice, age-dependent adipocytic conversion of the
marrow is highly strain-dependent (5). Notably, the C57BL/6
murine strain, which constitutes the most widely used model
for experimental hematopoiesis, presents the lowest degree of
BM adipocyte content upon homeostatic skeletal maturation.
However, upon hematopoietic ablation (e.g., after chemo-
or radiotherapy) a massive adipocytic conversion has been
consistently described in humans and across different mouse
strains. The BM is thus heterogeneous depending on specific
skeletal location, age, and physiological condition [reviewed
in (6)].
At the single-cell level, however, BMAd heterogeneity was
first described by the terms “labile” and “stable” (7). These terms
were coined upon the discovery that performic acid Schiff (PFAS)
positive and negative stains respectively differentiate “labile”
BMAds interspersed within the hematopoietic red BM, which
respond to hematopoietic demand (PFAS positive) from “stable”
BMAds comprising the non-hematopoietic yellow BM of the
distal long bones (PFAS negative) (4, 5, 7). The integration
of macroscopic characteristics and single-cell response at the
tissue level resulted in the terms “regulated” BM adipose tissue
(rBMAT) and “constitutive” BMAT (cBMAT), and prompted
further investigation on their differential skeletal distribution, cell
size, and relative lipid composition. Mechanistically, specific loss
of rBMAT with conservation of cBMAT has been described in
the long bones upon cold exposure, and in lipodystrophic Ptrf
knock-out mice, while an overall loss of BMAds is characteristic
of c-kit mutantW/Wvmice (5, 8, 9).
The association between increased vertebral fracture risk
and BM adiposity (BMA) in humans, as well as hematopoietic
stem cell (HSC) quiescence and BMA has prompted increased
interest in marrow adiposity. Adipocytic conversion of the
marrow has been associated to increased vertebral fracture
risk in humans, although a cause-effect relationship is not
clearly established (10). While mature BMAds generally induce
HSC quiescence in humans and mice, BMAd precursors,
and their adiponectin-expressing immature counterparts
support hematopoietic expansion in vitro and in vivo (11–18).
In mouse models and patients suffering acute BM failure
or receiving chemo- or radiotherapy, a rapid and massive
adipocytic infiltration of the BM takes place (“red-to-yellow”
transition). Following treatment with intensive chemotherapy,
and sometimes HSC transplantation, hematopoietic recovery
ensues when BMAds recede and functional hematopoiesis is
restored (“yellow-to-red” transition). In the clinic, hematopoietic
activity is assessed by pathologists’ scoring of hematopoietic
cellularity in trephine bone biopsies of the iliac crest, and is
functionally correlated with circulating blood cell counts (19).
Hematopoietic cellularity assessment at low power examination
is performed systematically for all diagnostic trephine biopsies,
and complementary to immunohistochemistry molecular and
cytogenetic techniques for establishing the diagnosis of certain
hematological disorders characterized by either hypercellularity
(e.g., myeloproliferative neoplasias) or hypocellularity (e.g.,
hypoplastic bone marrow failure syndromes), or to follow disease
progression and response to treatment (e.g., myeloablation for
acute leukemias).
In vivo, Gold Standard quantifications of BMA in the research
setting are contrast-enhanced (CE) osmium tetroxide (OsO4)
lipid staining coupled to micro-computerized tomography
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(µCT) for rodents, and magnetic resonance imaging (MRI)
fat-to-water ratio for human. Although highly informative,
especially on higher resolution such as nano-CT, this method
is costly and sample preparation requires handling of highly
toxic products. Thus, accessibility to CE µ/nanoCT and/or MRI
expertise can be limited outside of clinical laboratories or specific
research settings.
Given the context-dependent heterogeneity of BM
compartments and the challenges associated to the accessibility
and longitudinal reproducibility of Gold Standards, we set out
to develop a tool that could provide quantitative information
on both BMA and hematopoietic cellularity with means
accessible to most laboratories. Histological information
obtained from hematoxylin-and-eosin (H&E) stained sections
has long been the standard method to provide information
on the architecture of biological samples. While the BM is
a particularly difficult organ for histological analysis, in part
due to the soft and hard tissue that are juxtaposed, the overall
analysis of its multiple components (bone, blood progenitors,
adipocytes) provides important information to understand
its physiopathology. Available histomorphometric analysis
programs usually specialize in detecting individual components,
and either require targeted staining protocols to detect specific
components within the bone fraction, or use less adapted tools
from the extramedullary adipose field to quantify the BMAd
fraction [(8, 9, 20–27); and also reviewed in (6)]. In order to
reduce inter-observer variability and to quantify sections of
entire murine bones rather than representative fields of view,
automation and standardization of methods are key. We have
developed a semi-automated digital pathology plugin compatible
with QuPath (28), named MarrowQuant, which subdivides
and quantifies the total marrow area (Ma.Ar) in H&E stained
mid-sections of mouse bones. The plugin subclassifies an user-
defined area (“Tissue Boundaries,” see definitions under Image
Processing Logic) into four compartments: the mineralized bone,
the hematopoietic, adipocytic, and interstitial/microvascular
compartments, as well as an unattributed area if present. Upon
segmentation, MarrowQuant then provides a BMAd area
(Ad.Ar) and size distribution for individual adipocytes, both
in the context of BMAds and of extramedullary adipocytes.
MarrowQuant thus provides absolute and relative areas for
discrete BM compartments, calculating the hematopoietic
cellularity and adiposity on H&E stained sections from murine
whole-bone sections. Specifically, the results presented here
validate the use of MarrowQuant in murine bone marrow in
the context of aging as well as in longitudinal studies upon
radiation-induced aplasia, and show compatibility with the
analysis of human bone trephine biopsies. Additionally, the
stand-alone AdipoQuant plugin quantifies relative number
and performs adipocyte ghost size fragmentation on H&E-
stained extramedullary adipose tissue. Adipocyte ghosts are
the delipidated derivatives of adipocytes resulting from sample
processing and resembling void areas on H&E.
Our software is thus complementary to other available
plugins for BMA quantification [comparative review provided
in (6)] in that, together with more classically reported values
for individual adipocytes or bone components, it provides
quantification of hematopoietic cellularity within the range of
pathologists’ evaluations, while providing overall architectural
segmentation of the BM space. We expect MarrowQuant
will be a valuable addition to the rapidly evolving Digital
Pathology field for use in a fundamental research setting
or as a tool for the “digitally-enhanced” pathologist in the
clinical setting.
RESULTS
Development of the Digital Plugin
Based on a combination of color and texture of whole-
bone H&E stained sections as compared to background,
we found MarrowQuant to most reliably perform marrow
quantification when set to segment bone sections into four
mutually exclusive detected compartments (Figure 1): (i)
cortical and trabecular bone, (ii) nucleated/hematopoietic
cells, (iii) BMA, based on adipocyte ghost detection, and (iv)
interstitium/microvasculature, which recognizes both red
blood cells (RBCs) and the eosinophilic protein or serous
infiltrate that fills the remaining marrow space. If present, areas
within the marrow space that are not recognized as any of the
above will be categorized and shown as “Undetected area.”
The Ma.Ar is used as denominator (see “Image processing
logic” for definitions) to calculate the percentage of each of
the detected areas apart from percentage bone which the user
may calculate themselves. Percentage of trabecular bone can
be calculated if the tissue boundaries encompass only the
marrow cavity, whereas percentage of cortical plus trabecular
bone can be calculated if the tissue boundaries also include
the cortical bone. From the adipocyte ghost segmentation,
MarrowQuant additionally approximates the adipocyte count
and size distribution. This function can also be applied to
extramedullary adipose tissue sections with the stand-alone
AdipoQuant function (Figure 2). The MarrowQuant plugin
for bone sections operates through QuPath using Fiji as
an extension, thus allowing the user to work with a more
intuitive interface.
Summary of the Image Processing Logic
The workflow underlying theMarrowQuant processing is shown
in Figure 3. Image files from total slide scans acquired at 20x
magnification (VSI format or extracted TIFF files) are directly
loaded into QuPath for processing (Figure 3A). Firstly, and prior
to image processing, the user must manually identify the region
of interest (ROI) to be analyzed, denoted as “Tissue Boundaries”
(Figure 3B). The wand tool in QuPath greatly simplifies this
step. The user may also classify at this step regions that should
be excluded from processing as “Artifacts.” In our dataset,
we excluded significant fixation artifacts at this step, which
are common upon retraction of the marrow tissue from the
endosteum. For our dataset, we also systematically excluded the
retraction artifact that creates a central vein lumen. Secondly, a
representative small area within the Tissue Boundaries must be
defined as “Background” and will serve as a reference background
correction factor for the whole ROI. These regions are selected
manually by the user with built-in drawing tools in QuPath and
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FIGURE 1 | Masks of bone marrow compartment areas detected by MarrowQuant. (A–E) Proximal tibia and (F–J) caudal vertebra (Cd2). Arrowheads in (A,F)
represent manually excluded artefacts. (A,F) Unprocessed H&E image, (B,G) bone detection (green), (C,H) nucleated cell detection (violet), (D,I) adipocyte ghost
detection (yellow), (E,J) interstitium and microvasculature (pink). Image from the proximal tibia at day 15 post lethal irradiation and total bone marrow transplant (A)
and caudal vertebra 2 (F) of a C57BL/6 2-months-old female mouse housed at room temperature fed a standard ad libitum chow diet. Scale bars are 50µm (A–E)
and 100µm (F–J). MarrowQuant user-defined parameters set at recommended values for bone marrow analysis (minimum adipocyte size: 120 µm2, maximum
adipocyte size: 5,000 µm2, minimum circularity: 0.3, exclude edges: false).
FIGURE 2 | Extramedullary adipocyte fragmentation by AdipoQuant. (A) unprocessed image, (B) adipocyte ghost membrane detection and fragmentation (cyan), (C)
adipocyte size fragmentation distribution. Omental adipose tissue from a C57BL/6 10-weeks-old female mice housed at room temperature fed a standard ad libitum
chow diet. Scale bars are 50µm. AdipoQuant user-defined parameters set at recommended values for extramedullary adipocytes (minimum adipocyte size: 300 µm2,
maximwn adipocyte size: 2,500 µm2, minimum circularity: 0, exclude edges: true). Binning has been set to 250 µm2.
assigned the corresponding annotation class (see MarrowQuant
Demo in Supplementary Video 1, Supplementary Datasheets 1
and 2). Preset parameters for adipocyte ghost circularity,
roundness, and size are defined, but may be changed by the
user depending on their application (e.g., tissues of different
origin). For our dataset, we kept these parameters conservative to
include all possible adipocytes and thereby test the robustness of
MarrowQuant (see Methods and Figures 1, 2 legends for details).
More restrictive values can be set and should be determined by
the user on their particular dataset.
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FIGURE 3 | Flow diagram of MarrowQuant logic. (A) A slidescan is acquired of an H&E stained bone section and loaded into QuPath. (B) User defines Tissue
Boundaries, Background, and Artifacts with the help of the magic wand tool. (C) MarrowQuant is run on the created qProject in single or batch mode with preset or
user-adjusted parameters. (D) Results can be saved as bone marrow mask images and a.txt file of area and calculated outputs. (E) User and/or pathologists’
feedback is integrated by removing false-positive adipocyte selection and if necessary, processing images with adjusted adipocyte parameters.
Extramedullary Adipocyte Quantification With
AdipoQuant
As suggested by the opposing effects of extramedullary adipocyte
hyperplasia and adipocyte hypertrophy, the measurement of
adipocyte size and number has become relevant in the context
of multiple patho/physiological conditions (29, 30). We thus
developed AdipoQuant to provide the adipocyte detection
function as a stand-alone plugin which detects the total area
covered by adipocyte ghosts and identifies individual adipocyte
ghosts through recognition of the remaining membranes,
providing a fragmentation size distribution count which can
be applied to extramedullary white adipose tissues (Figure 2).
Of note, adipocytes can only be identified as lipid ghosts in
H&E images, as the lipid content in the vacuoles is dissolved
on the alcohols used for the processing. Changes in relative
adipocyte size of a whole adipose tissue may be thus quantified
with the AdipoQuant script directly. The user must manually
outline “Tissue Boundaries,” unwanted “Artifacts,” and the
“Background” as described above. Not drawing any “Tissue
Boundaries” will result in the entire image being analyzed. A.txt
file is generated upon processing which lists the adipocyte ghost
fragmentation count and size. The tool relies on identification
of intact, clearly-stained H&E membranes for the most reliable
generation of a watershed algorithm that fragments the mask.
A mask is a pixel annotation of a specific region of the
original image resulting from image processing (31). Therefore,
a reliable size distribution is highly dependent on the quality
of sample preparation (including staining, sectioning, and
image acquisition).
Bone Marrow Quantification With MarrowQuant
Following the initial manual steps performed by the user in
setting “Tissue Boundaries,” excluding “Artifacts,” and defining
the “Background” within the QuPath environment as described
above (Figure 3B), the MarrowQuant plugin first identifies the
bone compartment within the given “Tissue Boundaries.” The
bone mask is then subtracted to generate the total area of
interest that we define as the “Total Marrow Area” (Ma.Ar)
ascribing to the nomenclature recommendations for BMA
(32). Within the “Total Marrow Area,” nucleated cells are
detected to generate the “Hematopoietic Cellularity” mask. A
watershed mask then detects and defines adipocyte ghosts by
their intact cell membranes in the remaining area to generate
the “Adiposity” mask. Finally, both the serous infiltrate and the
RBCs, located either within the microvasculature or dispersed
across the marrow space, are detected based on their eosinophilic
properties to define the “Interstitium/microvasculature” mask.
The remaining area within the “Total Marrow Area,” if
any, is then quantified as unattributed “Undetected Area.”
The five masks are mutually exclusive in the priority order
specified above (Figure 3C). Therefore, “Total Marrow Area”
(Ma.Ar) constitutes the sum of “Hematopoietic Cellularity”
plus “Adiposity” plus “Interstitium/microvasculature” plus the
unattributed “Undetected Area.” Derived parameters are the
adipocyte size fragmentation distribution, and the ratio of
hematopoietic area over the hematopoietic and adipocytic areas
combined (see Equations 1 and 2 below). A mask output for the
four defined compartments overlaid on the original image lets the
user confirm the results (Figures 3D,E).
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FIGURE 4 | Correlation to gold standards for MarrowQuant bone marrow adiposity and hematopoietic cellularity measurements. (A) MarrowQuant adipose area vs.
osmium-tetroxide contrast-enhanced CT measurements of lipid (n = 23 bones, R2 = 0.84). Quantifications performed on femurs and tibiae of 18-months-old male
mice, 8-weeks, 9-months, or 18-months-old female mice and of a select ion from (C). (B) µCT rendering (white: osmium-tetroxide stained lipids; blue: undecalcified
bone) of a tibia from an 18-months-old C57BL/6 female mouse. (C) MarrowQuant “cellularity” (Equation 1) vs. Pathologists’ “cellularity” assessment on the
“validation-set” of images of full-length bones (Pathologists n = 4, images n = 59, R2 = 0.93). (D) MarrowQuant percent Hematopoietic Area (Equation 2) vs.
Pathologists’ “cellularity” assessment of the “validation-set” (Pathologists n = 4, images n = 59, R2 = 0.93). Evaluations done for femurs and tibiae of 2-months-old
female mice at 0–42 days post lethal irradiation and transplant of 125,000 total bone marrow cells. All mice were C57BL/6 housed at room temperature and fed a
standard ad libitum chow diet. OsO4, osmium tetroxide; µCT, micro-computerized tomography.
Validation of MarrowQuant With Gold
Standards
µCT is an established technique used to quantify changes in bone
mineral density and bone architecture. It is now widely used
in the field of BMA for lipid detection. Ex vivo CT imaging of
the native bone is combined with a second CT acquisition after
bones have been decalcified and stained with the highly lipophilic
dye OsO4. This procedure is usually referred to as OsO4-
contrast-enhanced µCT or OsO4-CE-µCT. The ground truth
assessment of hematopoiesis constitutes pathologists’ assessment
of H&E stained paraffin- or plastic-embedded bone sections.
We therefore compared these Gold Standard evaluations of
murine marrow, first for BM adiposity then for hematopoietic
cellularity, to MarrowQuant detection. Importantly, mid-bone
sections were defined by a complete bone silhouette plus the
presence of the distal marrow space in the mid-sagittal tibial
sections, and the femoral head marrow space in mid-longitudinal
sections of the femur.
BM Adipose Quantification
We first compared the volumetric assessment of lipid content
via OsO4-CE-µCT in C57BL/6 murine long bones to the
MarrowQuant two-dimensional assessment of BM adipose area
inmid-bone sections. Quantification of contralateral bones (right
vs. left) with the two techniques over a range of percentage
adiposity spanning from 0 to 64% indicates a high correlation
(Figure 4A, n = 23, R2 = 0.84) despite the comparison of a
volumetric (Figure 4B) with a two-dimensional assessment. In
our dataset, 2D quantification of mid-sagittal sections are thus
a robust estimate of volumetric renderings of bone and adiposity
in the contralateral bone.
BM Hematopoietic Quantification
In spite of the species-specific differences discussed later, we
decided to compare the performance of MarrowQuant with
pathologists’ assessment of hematopoietic cellularity in murine
bones. To set up the MarrowQuant code and optimize the
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model parameters we curated a “training-set” of 89 images
from murine bones at homeostasis or post-irradiation aplasia,
spanning pathologist evaluated hematopoietic cellularity from 0
to 100%.
In human pathology, hematopoietic “cellularity” is defined as
“the proportion of cellular elements relative to marrow adipose
tissue” (33, 34), and therefore uses the sum of the hematopoietic
and adipocytic areas as denominator for the calculation of
“cellularity” (Equation 1, % hematopoietic cellularity). The
pathologist definition of hematopoietic “cellularity” underscores
the reciprocal relationship between the hematopoietic and
adipose tissue in the BM.
"Cellularity" =
hematopoietic area
(hematopoietic+ adipocytic) area
(1)
We found a strong linear correlation between the MarrowQuant
calculation of hematopoietic cellularity and the mean of the
pathologist’s scoring of “cellularity” (Equation 1, Figure S1A,
n = 89, R2 = 0.98). MarrowQuant “cellularity” values thus
fell within the inter-observer variability of four independent
pathologists’ assessments, with a higher correlation to the
mean at high “cellularity” values. MarrowQuant performance
at estimating “cellularity” was subsequently confirmed on an
independent “validation-set” from 59 images of murine long
bones (Figure 4C, n= 59, R2 = 0.93).
In accordance with the MarrowQuant logic to subclassify the
marrow space into three different compartments (hematopoietic,
adipocytic, and interstitium/microvasculature) and an
unattributed “undetected area” when present, we then calculated
the hematopoietic cellularity as defined by hematopoietic area
over total Ma.Ar (Equation 2, % Hematopoietic Area).
% Hematopoietic Area =
hematopoietic area
total marorw area
(2)
We found that MarrowQuant measurement of percent
Hematopoietic Area (Equation 2) progressed linearly when
compared to the mean of the pathologists’ “cellularity” scoring
(Equation 1). Equation 2, however, better correlates to the mean
of the pathologists’ “cellularity” scoring at low hematopoietic
content (Figure S1B, n = 79, R2 = 0.96). The MarrowQuant
measurement of percentage Hematopoietic Area was also
validated on an independent “validation-set” (Figure 4D,
n = 59, R2 = 0.93). Note that MarrowQuant evaluation of
percent Hematopoietic Area does not reach 100%, as opposed to
pathologist-rated “cellularity,” precisely because it uses a different
denominator that takes into account the entirety of the marrow
space including the interstitium/microvasculature compartment.
In conclusion, in C57BL/6 mice,MarrowQuant 2D evaluation
of BM adiposity (% Adipocytic Area/ Total Ma.Ar) in mid-bone
sections highly correlated with gold standard OsO4-CE-µCT
detection of marrow lipids in 3D measurements. Evaluation of
hematopoietic content withMarrowQuant also highly correlated
with gold standard “cellularity” scoring by pathologists. For
evaluation of the hematopoietic compartment, MarrowQuant
generates results according to two different equations that
differ on the denominator. Equation 1 better correlates to the
mean of the pathologist scoring in samples of high cellularity,
while Equation 1 better correlates at low cellularities. For
MarrowQuant evaluation of the percentage Hematopoietic Area
as compared to other BM compartments, only Equation 2
is applicable as MarrowQuant uses Total Marrow Area as a
denominator for all compartments.
Application of MarrowQuant
We hypothesized that quantification of BM components as
a first architectural assessment of BM regeneration may
provide valuable information on homeostatic states and disease
progression. The C57BL/6 mouse constitutes the most widely
used animal model in experimental hematopoiesis. Its skeleton
is often assumed to be homogeneously hematopoietic, whereas it
has now been well-described that BMAds are interspersed within
specific regions of the marrow (5, 17).
Skeleton of the Homeostatic C57BL/6 Female Mouse
Here we provide for the first time a quantitative BMA skeletal
map of the homeostatic C57BL/6 8-weeks-old female mouse,
which reveals a transition of low adiposity, red BM (high
cellularity) to high adiposity, yellow BM (low cellularity) in
the proximal to distal regions of the skeleton (Figure 5).
This transition is most notable in the proximal-to-distal tibia
(Figure 6C), and highly predictable in the caudal vertebrae of the
tail at the level of the Cd3–Cd4 transition (Figures 5G,H). The
extremities of the skeleton such as the metatarsals or caudal tail
vertebrae (e.g., Cd5, 76 ± 4% adiposity) are highly adipocytic
whereas the axial skeleton such as the sternum (2.0 ± 0.1%
adiposity) and thoracic/lumbar vertebrae (e.g., L4, 6 ± 1%
adiposity) are almost entirely hematopoietic. These gradients of
red and yellow marrow have also been reported in human, where
the adult distal skeleton is nearly completely adipocytic (3, 35).
Location-specific BMA may be explained from the perspective
of skeletal development, musculoskeletal forces, and temperature
gradients (36).
Long Bones of the 18-Months-Old C57BL76 Female
Mouse
BMA has been described to increase with age, which may in
part be attributed to the terminal differentiation and depletion
of BMAd precursors, and in part to the potential protective
function assigned to mature BMAds of surrounding cells such as
low-proliferating HSCs. In the clinical diagnostic setting, values
for normal cellularity of standard trephine biopsies from the
pelvic bone in humans are interpreted according to age such
that normal, age-adjusted cellularity is described by the formula:
normal cellularity= 100% – age (years)± 20% (33).
In C57BL/6 mice, significant differences in BMA are seen
between 8 weeks and 18 months of age (Figure 6). The femurs
of juvenile mice at 8 weeks of age contain relatively few BMAds
(2 ± 1%) that are mostly located at the distal site. With age,
BMA in the femur of female C57BL/6 mice increases slightly
to 4 ± 2% adiposity (P = 0.03) and also appears in the
proximal femur (Figures 6A,B). While the distal tibia already
contains BMAds at an early age with 4 ± 1% adiposity at 8
weeks old, BMA expands further up the BM cavity, especially
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FIGURE 5 | Red-to-yellow marrow transition in homeostasis. Eight-weeks old C57BL/6 reconstructed skeletal map locates the proximal-to-distal red-to-yellow
marrow transition in the first caudal vertebrae and proximal-to-distal tibia approximately at the site of the fibular insertion. Skeletal map and quantifications performed
for bones of female mice housed at room temperature and fed a standard ad libitum chow diet. Percentages of MarrowQuant cellularity (BM-C) and adiposity (BM-A)
from Equation 2 are shown for select bones (femur, n = 6; tibia, n = 6; sternum, n = 10; lumbar, n = 7; tail, n = 6; all are mean ± s.d.). Cd, caudal (vertebrae); L,
lumbar; S, sacral; T, thoracic.
at the epiphysis of the proximal tibia to 31 ± 14% (P = 0.01)
at 18 months old (Figures 6C,D). BMAd size fragmentation
distributions tibia in homeostasis (8-weeks-old C57BL/6 females)
shows the distribution shifted toward larger adipocyte size in
the distal tibia as compared to the proximal tibia (Figure 6E) as
has been previously reported (5). Adipocyte size fragmentation
in the tibiae of aged mice (18-months-old C57BL/6 females)
show comparatively larger adipocytes as compared to the
young animals (Figure 6F). Interestingly, older mice present no
difference in the size distribution of distal vs. proximal adipocytes
across the tibia, suggesting reduced remodeling as compared to
young mice (Figures 6E,F, compare orange lines). BMA is also
increased in the proximal tail of aged mice while maintaining
the red-to-yellow marrow transition in the first caudal vertebrae
(Figures 6G,H). Other strains such as the C3H, with high bone
mass, or NSG, that are prone to obesity, have higher BMA than
the C57BL/6 strain (not shown).
Irradiation-Induced BM Aplasia in the Skeleton of the
C57BL/6 Female Mouse
In certain pathophysiological circumstances such as in
osteoporosis, anorexia, or obesity, the marrow becomes
more adipocytic. In stress hematopoiesis, such as after
chemo/radiotherapy to overcome malignant hematopoiesis,
the plasticity of the marrow becomes very apparent. In the
timespan of several weeks, the marrow undergoes a rapid
“red-to-yellow” conversion, and then recovers thanks to residual
or transplanted HSCs. We set up a murine stress hematopoiesis
model by applying lethal irradiation immediately followed
(day 1) by transplantation of a limited number of healthy BM
cells. In this model, the marrow initially becomes necrotic and
highly hemorrhagic due to the breakage of the marrow-blood
barrier (day 4–10 post-transplant), such that the marrow
space is characterized by a high content of RBCs and serous
infiltrate. During this time, circulating white blood cells and
platelets are reduced 10-fold (Figure S2). Shortly thereafter
BMAds begin to occupy the marrow space such that the BM
reaches peak adiposity at days 13–17 post-transplant in the
femur and tibia (Figures 7, 8A,B). At this time, and in parallel
to revascularization, the new hematopoietic system starts to
recover. Around day 25 post-transplant, circulating blood levels
show exit from severe thrombo- and neutropenia (<200 and
<0.5 cells/mm3, respectively) (Figure S2). Over the next several
weeks, blood counts increase and eventually return to normal
levels of functional hematopoiesis. Importantly, the overall peak
of aplasia and time of recovery in this model closely resembles
that observed in patients undergoing HSC transplantation
(37, 38).
Examination of the C57BL/6 skeleton at murine peak of
aplasia shows that myeloablation renders the entire skeleton
of the C57BL/6 8-weeks-old female mouse highly adipocytic
and aplastic (Figure 7). Specifically, we find at day 17 post-
irradiation a low hematopoietic cellularity (average BM-C
15–37%) in skeletal sites that are highly hematopoietic at
homeostasis (average BM-C >50% hematopoietic cellularity,
e.g., axial skeleton including sternum and vertebrae Cd1-3)
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FIGURE 6 | Red-to-yellow transition with aging. Representative H&E images of femurs (A) tibiae (C). Note high adiposity on proximal and distal but not mid-shaft of
18-months-old female tibia. MarrowQuant analysis for (B) femurs (n = 3) and (D) tibiae (n = 3) from 8-weeks-old and 18-months-old C57BL/6 females. BM adiposity
is significantly higher in 8-weeks-old tibias vs. femurs (P = 0.0045) and in 18-months-old tibias vs. femurs (P = 0.0316). Hematopoiesis is greater in 18-months-old
femurs than tibias (P = 0.0993). Error bars represent mean ± s.d. P-values are indicated for hematopoietic compartment (purple) and adipocytic compartment
(yellow) are *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 by Student’s t-test for cellularity (black) and adiposity (gray). (E) BMAd fragmentation distribution of
the proximal (purple) and distal (orange) 8-weeks-old tibia (n = 10) vs. (F) the 18-months-old tibia (n = 3). ***P < 0.001 by multiple comparisons test. Representative
mid-longitudinal H&E section of bone marrow compartments in the proximal-to-distal caudal vertebrae of (G) 8-weeks-old and (H) 18-months-old mice. MarrowQuant
analysis of caudal vertebrae in (I) 8-weeks-old (n = 6) and (J) 18-months-old (n = 4) female mice. ****P < 0.0001, **P < 0.01 for cellularity and adiposity and *P <
0.05 for cellularity by two-way ANOVA. Mice were C57BL/6 females housed at room temperature and fed a standard ad libitum chow diet. BM, bone marrow; BMAd,
bone marrow adipocyte; H&E, hematoxylin and eosin; mo, month; wk, week.
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FIGURE 7 | Red-to-yellow-to-red transition in bone marrow aplasia and hematopoietic recovery. Skeletal map of an 8-weeks-old C57BI/6 female mouse 17 days
post-lethal irradiation and transplant of 125,000 total bone marrow cells. Results for MarrowQuant quantification of hematopietic cellularity and adiposity are shown
for select bones (femur, n = 3; tibia, n = 10; sternum, n = 3; lumbar, n = 4; tail, n = 4, all error bars represent mean ± s.d). Note that average adiposity (BM-A) and
hematopoietic cellularity (BM-C) are homogenous across the axial skeleton (lumbar vertebrae and sternum) and femur, while the tibia and caudal vertebrae present
higher adiposity and lower cellularity. BM-C is higher in sternum than Cd5 (P = 0.0001) and Cd4 (P = 0.0002), while BM-A is higher in Cd-5 (P < 0.0001) and Cd4
(P = 0.0002) than sternum by Student’s t-test. Cd, caudal (vertebrae); L, lumbar; S, sacral; T, thoracic.
(Figures 5, 7). Site-specificity variations including a proximal
to distal hematopoietic gradient are conserved, and can be
reliably measured in the lumbar to caudal transition (Figure 8F).
Moreover, longitudinal analysis of the “red-to-yellow-to-red”
transition in femurs (Figure 8A) and tibiae (Figure 8B) also
indicated a peak of adiposity at days 14–17 post-irradiation, and
a higher peak of adiposity in the tibiae than in the femurs.
The first 2 weeks post-irradiation entail important vascular
remodeling. Quantitatively, the interstitium/microvasculature
even constitute the most important compartment in some of the
proximal sites (e.g., femur D4-10, Cd1 on day 17). Interestingly,
when samples of varying cellularities post-irradiation are
compounded (all images from Figure 4D), the measure of
hematopoietic cellularity presents preferential reciprocity with
the adiposity and interstitium/microvasculature compartments
(Figure S3), suggesting that hematopoietic expansion or
retraction might be the driver of marrow remodeling. Changes
in BMAd size fragmentation of lethally irradiated mice as
compared to homeostatic C57BL/6 8-weeks-old females, indicate
a shift toward more and larger BMAds in the proximal tibia
(Figures 6E, 8C, compare purple lines). The increase in number
and size signifies hyperplasia and hypertrophy of the labile
BMAds in the proximal tibia at the peak of aplasia putatively
originating from a differentiation of skeletal stromal/stem cells
or pre-BMAds. However, a small change in size fragmentation
in the distal tibia, which is predominantly composed of stable
adipocytes, indicates that constitutive BMA could also be
undergoing some degree of remodeling. A similar “red-to-
yellow-to-red” conversion occurs in the femur during the time
of aplasia.
Just as with CE-µCT in homeostasis, we set to validate
our findings with MRI as an available tool for Gold Standard
measurements of BMA. BMA quantification performed in
murine limb bones was possible through access to a 9.4 Tesla
magnet for small animal imaging. We chose MRI in vivo imaging
as an alternative to ex vivo imaging because repetitive imaging
allows for a very significant reduction on the number of animals
required to study the kinetics of marrow recovery, as compared
to the ex vivo terminal experiments. MRI analysis validated the
time course ofmarrow recovery in the femurs ofmice undergoing
lethal irradiation followed by BM transplantation, as compared
to MarrowQuant analysis of full bone mid-longitudinal sections
(Figure 8D). Additionally, MRI measurements also revealed that
the proximal femur appears to recover more rapidly (max at
D10 and decreases, Figure 8D) than the distal portion (max
D15–D30, Figure 8D), which already contains some BMAds
during homeostasis (stable/constitutive BMAds). In conclusion,
volumetric measurements by MRI show a progression of fat
signal that corresponds to the bidimensional quantification of
adipocyte ghosts observed on histology with one of the most
commonly used techniques to estimate fat content of a tissue
in vivo (39).
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FIGURE 8 | Red-to-yellow-to-red transit ion in bone marrow aplasia and hematopoietic recovery. MarrowQuant results for quantifications of (A) femurs and (B) tibiae
in hematopoietic recovery at 0–42 days post lethal irradiation and transplant of 125,000 total bone marrow cells in 2-months-old C57BL/6 female mice. ****P <
0.0001, ***P < 0.001, **P < 0.01, *P < 0.05 by two-way ANOVA for cellularity (black) and adiposity (gray). (C) BMAd size fragmentation distribution in the proximal
and distal tibia at peak of aplasia on days 17–21 (n = 10 tibiae) from MarrowQuant measurements extracted from (B). (D) Changes in BMA fraction measured by MRI
after lethal irradiation and total BM transplant as a time-course of recovery in the whole femur in vivo under the same conditions as (A), n = 3–5 bones per time point.
***P < 0.001 by multiple comparisons test. (E) Mid-longitudinal H&E section and (F) quantification of bone marrow compartments in the proximal-to-distal caudal
vertebrae at day 17 post lethal irradiation and transplant of 125,000 total bone marrow cells in 2-months-old C57BL/6 female mice. ****P < 0.0001, **P < 0.01, and
*P < 0.05 for BM adiposity by two-way ANOVA. All error bars represent mean ± s.d. Mice were housed at room temperature and fed a standard ad libitum chow diet.
BM, bone marrow; BMA, bone marrow adiposity; BMAd, bone marrow adipocyte; Cd, caudal (vertebrae); D, day; L, lumbar; MRI, magnetic resonance imaging; S,
sacral; T, thoracic.
Human Trephine Biopsies
MarrowQuant has been developed for quantification of mouse
bone H&E stained paraffin sections and is also able to detect BM
compartments in human trephine biopsies (Figure S4). While
samples analyzed from mice have the entire bone encompassing
the marrow still intact, trephine biopsies although similar in size
(roughly 2 cm long and 2mm in diameter) also have trabecular
bone but not the cortical bone encompassing the marrow. Cells
are larger in general (40) thus presenting a different texture
to stained mouse sections and may also present with a larger
degree of serous infiltrate that is not detectable with the current
version of MarrowQuant. Additionally, due to their surgical
nature, trephine biopsies are by definition hemorrhagic with
RBCs detected throughout the majority of the interstitium. Note
that currently MarrowQuant cannot separate the interstitial and
the microvascular components. Despite these differences, initial
correlations, indicate promising results (pathologists n = 2,
images n= 32, R2 = 0.85, Figure S4F).
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DISCUSSION
MarrowQuant provides a means to quantitatively evaluate
overall BM architecture in H&E-stained sections in single-
or batch-mode by subclassification into the bone, adipose,
hematopoietic, and interstitial/microvascular compartments.
Systematic comparison of training and validation sets with gold
standards for adiposity and hematopoietic cellularity showed
robust correlations. To our knowledge, this is the first semi-
automated digital pathology tool to quantitatively evaluate
murine marrow composition and in particular the hematopoietic
and interstitial/microvascular compartment. Other approaches
in murine and human tissues have been described which focus
mainly on bone morphometry and use stains non-compatible
with concurrent hematopoietic evaluation such as Goldner’s
Trichrome or Von Kossa or TRAcP (6, 41).
While standard practices for evaluating bone morphometry
and hematopoietic cellularity have existed for many years,
the field of BMA is newly emerging and thus methods
of quantification are currently being defined. Automatization
of sample preparation and quantification is required to
increase accuracy, comparability, and reproducibility of results
(6). This is rapidly developing in clinical and experimental
pathophysiology with image-analysis programs emerging for
quantification and detection of specific cell types related to
disease progression (42, 43). Indeed, the high-quality image
collection of over 192 murine H&E-stained bone sections
that composes our dataset may become useful in training
deep-learning algorithms for full automatization and finer
detection of BM compartments. Histomorphometry reveals
abundant architectural information about a specimen that may
be missed by the gating inherent to immunofluorescence. In
the future, highly multiplexed immunofluorescence staining
has the possibility to reveal as much information of cellular
composition as conventional flow cytometry analysis while
conserving information on tissue structure (44). MarrowQuant
constitutes an example of a histomorphometry digital pathology
tool that can provide quantitative data complementary to visual
analysis of architectural features.
BM Compartment Detection
MarrowQuant relies on the user’s definition of a region of
interest and the exclusion of artifacts that may arise from sample
processing (such as fixation retractions). High-quality stained
sections provide best results as the tool relies on intact adipocyte
membranes and an even staining coloration for quantification.
Image acquisition is also an important initial aspect of
preparation as the tool relies on background identification,
and therefore stitched images should not show a gradient
that would produce an uneven shade of the background and
influence subsequent processing steps. Despite these measures
that must be accounted for during setup, the automation of image
quantification withMarrowQuantmeans that numerous samples
can be batch processed. While the automated quantification
is up to four times longer than a pathologists’ assessment of
hematopoietic cellularity (2min on a standard laptop computer
vs. less than a minute per image for pathologists), it has the
advantage of providing quantitative information on several BM
compartments at once in a highly reproducible manner.
The quantitative output for the bone, adiposity and
interstitium/microvasculature mask in the MarrowQuant
results is straight-forward. Two results are provided for the
quantification of the hematopoietic compartment due to
discrepancies in the most appropriate denominator to be used.
For users interested in subdividing the BM compartment (e.g.,
Figures 5–8) the only relevant output for the hematopoietic
compartment is the result of Equation 2. For users who would
like to use MarrowQuant exclusively for quantification of the
hematopoietic compartment, similarly to pathologist evaluation
of “cellularity,” we propose using Equation 1. Note that datasets
with a prominent number of low cellularity samples (<30%
cellularity) may benefit from choosing Equation 2 (Figure 7).
The user should be aware of some limitations of
MarrowQuant regarding BM segmentation. Firstly, the current
version of MarrowQuant provides area values which compound
the full area of interest. Thus, MarrowQuant calculations do
not provide a regional gradient of cellularity or adiposity within
each bone unless the user manually fragments the bone into
separate images. A measure of dispersion across a single bone
may be of interest when the marrow compartment is expected
to be highly heterogenous. This is the case, for example, in early
hematopoietic recovery post-aplasia, where loci of hematopoiesis
appear heterogeneously across the marrow space.
Secondly, osteoblasts or bone lining cells with prominent
nuclei that have a similar color and texture to the nucleated
cells that make up the hematopoietic mask, may be included in
the hematopoietic area if detached from the endosteal surface
(Figures S5A,E). MarrowQuant contains a bone mask dilation
feature that will prevent cells in direct endosteal position
from being counted in the hematopoietic area. However, if
detached, depending on the extent of the artifact and the
overall hematopoietic cellularity of the sample, such cells may
be misclassified as a significant portion of the hematopoietic
mask. In this case, the user should manually exclude them as
artifacts. Other non-hematopoietic cells with prominent nuclei,
likely including both bone lining cells (45, 46) and stromal cells
are expected to be recognized within the hematopoietic mask or
fall within the undetected area.
Thirdly, since hematopoietic detection is based on
identification of nuclei, the area occupied by adipocytic
nuclei may contribute to the hematopoietic compartment
(Figures S5B,F). In our dataset, this phenomenon constitutes a
systematic bias of <5% (see crossing of MarrowQuant values on
x-axis, Figure 4D), which is an insignificant contribution to the
hematopoietic area in samples of medium to high cellularity, but
may add variability in samples of low hematopoietic cellularity
and high adiposity.
Fourthly, while the nuclei of megakaryocytes are correctly
assigned to the hematopoietic mask, their cytoplasm is often
included within the microvascular/interstitial compartment, and
sometimes identified as bone area due to their similar texture
and color (Figures S5C,G). These mis-assigned bone areas
are easily detected as squares within the marrow space, and
will be automatically subtracted from the total Ma.Ar. In our
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dataset, the area of mis-assigned megakaryocytes is minimal,
but this may become relevant in other biological contexts where
megakaryocytes are significantly enlarged and/or increased
in number (e.g., myeloproliferative neoplasms). Finally, the
interstitium/microvasculature is well-detected by MarrowQuant
but may be problematic when the RBCs and/or serous infiltrate
are lost upon tissue fixation in specific areas, such as on
hemorrhage with leakage of vessels, or in perfused samples.
The empty spaces must then be taken as artifacts to avoid
them being counted as adipocytes, although the total area of
interest is thus reduced to quantify the conserved tissue only.
A related inherent bias is the fact that the mid region of
the bone (e.g., mid-sagittal sections for the tibiae and mid-
longitudinal sections for femurs) often contains the central vein,
whose lumen is enlarged due to the fixation-related retraction
artifact. In the interest of consistency across the dataset, we
have opted to classify the enlarged central lumen as an artifact.
Sections across the lumen therefore contain a reduced “total
area of interest” for analysis. These are examples of issues
that the user should be familiar with, and aware of when
interpreting results.
Adipocyte Fragmentation
Adipocyte quantification on BM sections will be largely
dependent on the quality of the sample and absolute values must
be interpreted with caution. One caveat is that adipocyte size
fragmentation is a comparative measure andMarrowQuant may
hyper- or hypo-fragment adipocytes where membranes are not
clear (Figures S5D,H). In our dataset hypo/hyper-fragmentation
does not contribute to the overall adipocytic area as compared
to manual classification. However, when membranes are intact,
as is more often the case with extramedullary adipose tissue
due to the nature of the samples, hypo/hyper-fragmentation is
a negligible factor.
In our hands, the adipocyte-only detection function of
AdipoQuant is somewhat more convenient to apply on
extramedullary tissue than other current open-source softwares
developed specifically for white adipose tissue. Although the
number of adipocytes obtained are similar, the area identified
by AdipoQuant (or MarrowQuant at large) seems truer to
size. The fragmentation of the adipocytes lies clearly on the
membranes and not within the adipocyte itself when compared
to, for example, Adiposoft (Figure S6) (47). Identifying an
area of interest before quantification also allows the user to
quantify whole tissue sections and to eliminate regions that
may be irrelevant for a particular analysis (such as vasculature).
Thus, while Adiposoft may give a more accurate total adipocyte
count in samples of lower quality, MarrowQuant will be truer
to the total adipocytic area and distribution. Moreover, the
MarrowQuant adipocyte fragmentation and separate annotation
per adipocyte linked to the flexibility of QuPath, allows the
user to easily correct for false positives during the post-analysis
validation and eliminate them from the analysis.
Human Application
We have found that the most important difference affecting
MarrowQuant results between human and mouse lies in
the fact that hematopoietic nuclei are less densely packed
in human as compared to mouse marrow. Indeed, in our
experience, the cytosolic space of mouse hematopoietic cells
is relatively small in histological sections as compared to
human samples. Additionally, while mouse marrow samples
are encased by cortical bone, human trephine biopsies of a
similar size comprise only a small part of the entire bone and
thus the marrow space as seen in these histological samples
are not fully surrounded by cortical bone. Other processing
issues come from visible color differences between mouse and
human samples. The potentially duller stain of the human
samples has consequences on the efficiency for the thresholding
methods used in the code and can sometimes result in mis-
segmentation. The observed color difference may be due to the
nature of the samples, the preparation and staining protocols,
and/or subsequent storage of slides before image acquisition.
The method for decalcification of the bone may be different
which may influence bone staining. Additionally, human slides
were imaged weeks after staining whereas mouse image were
usually scanned days after staining. These points could explain
the observed color alteration in human samples. Technical
adaptations are ongoing for an improved quantification of
human BM in a later MarrowQuant release. In conclusion,
due to the different nature of human biopsies compared to
mouse samples, several parameters of the plugin must still
be optimized to obtain accurate and reliable measurements,
which will be the subject of a separate study and a new
software release.
CONCLUSION
H&E is the most common and routinely performed stain
in histopathology. MarrowQuant is a semi-automated
digital pathology tool and workflow for QuPath, that
quantifies four detectable BM compartments (adipocytic,
hematopoietic, osseous, interstitial/microvascular,
interstitium/microvasculature) and the remaining undetected
area, if any, on H&E stained sections of whole intact murine
bones.MarrowQuant was optimized for paraffin-stained sections
but could potentially be applicable to plastic-embedded samples
that are also widely used for histomorphometry. Despite some
discordances in mid-cellularity samples which also present a high
inter-observer variability, MarrowQuant cellularity calculation
falls within the range of pathologists’ estimations.
While the paraffin sections present only one slice of the
whole organ, in our experimental setup with mid-sections of
entire bones from C57BL/6 mice, the quantification correlates
highly with volumetric quantifications of the contralateral whole
bone by µCT combined with osmium-tetroxide staining. We
were also able to apply the non-invasive technique of MRI
in vivo to follow changes in fat signal on murine hematopoietic
recovery. The results correspond to MarrowQuant histological
assessment and correlate with blood recovery curves at peak of
aplasia. Moreover, MarrowQuant provides a size fragmentation
distribution of adipocytes and thus may additionally be applied
to H&E sections of extramedullary white (omental or inguinal)
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adipose tissue. This feature has been extracted to offer the
possibility of independent use fromMarrowQuant, and has been
named “AdipoQuant.”
Future iterations of the tool applied to human samples could
incorporate machine learning methods to overcome the hurdles
of the distinct morphology of human tissue and detection
of specific cells (e.g., macrophages and megakaryocytes with
large cytoplasms, bone-lining cells). Close collaboration with
hematopathologists will help to further develop this tool for
human tissues and potential clinical research and/or computer-
aided diagnostic applications.
METHODS
Mice
In vivo procedures were carried out in accordance with the Swiss
law after approval from the local authorities (Service Vétérinaire
de l’Etat de Vaud) and experiments were designed according
to the ARRIVE guidelines. Eight-weeks old C57BL/6J were
purchased from Charles River Laboratories International and
maintained at the Center for Studying Living System (CAV) at the
EPFL in microisolator cages. Mice were provided continuously
with sterile food and water ad libitum, and bedding. Mice were
housed at room temperature in 12 h light/dark cycles and fed a
standard ad libitum chow diet.
Human Samples
This work was performed under the approval of the local
ethical authorities (CER-VD). Images of human bone marrow
H&E stained paraffin sections from diagnostic samples of
patients undergoing treatment for acute myeloid leukemia were
received for analysis as blinded, anonymous images form the
Institute of Pathology at Lausanne University Hospital (CHUV).
The trephine biopsies were processed for standard pathology
diagnosis and H&E stained paraffin sections were scanned using
a 40x objective.
Bone Marrow Transplantation
Eight-weeks-old female C57BL/6 mice were lethally irradiated
with a total 850 rad dose in an X-ray radiator (RS-2000, RAD
SOURCE) 24 h before transplant. The dose was split in two
doses of 425 rads separated by a 4-h interval. Total bone
marrow cells were isolated from crushed bone marrow of 8-
weeks-old female C57BL/6J donor mice in phosphate buffered
saline (PBS, Life Technologies 10010056) solution with 1mM
EDTA (Thermo Fisher Scientific 15575020). Total BM cells for
transplantations by SR-S were obtained by flushing instead of
crushing. RBCs were removed by incubation with ice-cold lysis
buffer (BioLegend) for 30 s. Samples were filtered through a
70µm cell strainer (Sigma Aldrich CLS431751) and centrifuged
at 300 g for 10min at 4◦C. Recipient mice were injected with
125,000 donor cells via tail-vein injection. For at least 2 weeks
after lethal irradiation mice were treated with paracetamol and
antibiotics in the form of 30mg of Enrofloxacin (300µl of Baytril
10% solution, 100 mg/ml, Bayer) and 125mg of Amoxicillin
(2.5ml of Amoxi-Mepha 200 mg/4ml, Mepha Pharma AG) as
well as 500mg of Paracetamol (Dafalgan R©) to 250ml of drinking
water protected from light. Peripheral blood was collected to
assess blood recovery (blood volume 50 µl) and analyzed by
standard veterinarian blood cell counter (ABCTM). Mice were
sacrificed by CO2 inhalation.
Magnetic Resonance Imaging
All experiments were conducted on a 9.4T/26 cm horizontal
magnet (Agilent/Varian) using a home-built quadrature
transceiver of 20mm diameter loops (Figure S7). Animals
were anesthetized with 1.5% of isoflurane, respiration, and
temperature were monitored during the whole study. Animals
were placed on their side and the leg was immobilized in a
contracted position. A triple point Dixon acquisition (39) was
performed using a spin-echo based sequence (te = 9ms, tr =
1.5 s) with 10 coronal slices of 0.8mm on a FOV 25 × 20 mm2
(acq. Matrix 192 × 128). Dixon’s technique in combination
with a spin-echo based sequence minimized signal loss of the
marrow due to bone magnetic susceptibility. Three acquisitions
were performed with the echo acquisition shifted 0, 0.4, and
0.8ms corresponding to the fat-water chemical shift of 1,250Hz
at 9.4 T. Images were reconstructed using a homebuilt Matlab
script to extract water and fat maps. Phase unwrapping was
performed using a toolbox from Matlab file exchange (48). At
the end of the MR acquisitions, animals were sacrificed, tibia
and femur were dissected to conduct histology and validate MR
Dixon acquisitions.
Histology
Bones were extracted and cleaned of soft tissue. Long bones
and cranium were placed loosely in histology cassettes while
spine (including tail) and paws were placed in histology cassettes
(Simport M505-11) with sponges (Simport M476-1) to flatten
the samples for facilitated sectioning. Bones were fixed for 24 h
at room temperature in 10% neutral buffered formalin (VWR
11699404), then rinsed three times with phosphate buffered
saline (1x PBS) solution. Bones were decalcified in 20% sodium-
citrate (Sigma Aldrich 71405) and formic acid (ROTH 4724.3)
solution (v/v) for 30–36 h or in 0.4M EDTA pH 7.4 (Sigma
Aldrich 607-429-00-8) for 2 weeks (solution changed every 3
days) at room temperature. The two different decalcification
protocols resulted in similar quality of H&E-stained paraffin
sections. Bones were washed three times in PBS or under running
tap water for 2 h before transferring to 70% ethanol (Reactolab
96170). The tissues were submitted for stepwise dehydration and
embedded in paraffin blocks for sectioning at 3–4µm thickness
with a rotary microtome (RM, Leica microsystems). All cuts
were mid-bone sections (i.e., mid-longitudinal for femurs and
mid-sagittal for tibiae). Bone silhouettes that do not correspond
to those presented in Figures 5, 6 for mid-bone sections were
discarded. For mid-longitudinal sections of the femur, at the
proximal end, both the head and the neck should be visible,
while at the distal end, the two condyli (medial and lateral)
should be visible. For mid-sagittal sections of the tibia, at the
proximal end, the tibial plate should be intact with conservation
of the tuberosity and crest of the tibia; at the distal end, insertion
of the fibula as well as the lateral and medial malleolous at
the ankle joint should be visible. Femoral and tibial silhouettes
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that preserve these features should then preserve a contiguous
marrow cavity. After floating on a water bath to flatten, sections
were mounted on glass slides (Superfrost+ slides, Menzel
gläser). Paraffin sections were stained with Hematoxylin and
eosine (H&E) using the Tissue-Tek Prisma automate (Sakura)
and permanently mounted using the Tissue-Tek glass G2-
coverslipper (Sakura) to assess morphology.
Image Acquisition and Processing
Whole-slide images were acquired with an automated slide
scanner (Olympus VS120-SL) at 20x magnification with focus
points along the total area of interest or using the in-situ focus
mode using the accompanying software (Olympus VS-ASWL100
2.9). VSI files obtained from scanning were directly loaded into
QuPath for analysis on Windows or Mac operating systems.
Extracted TIFF files were also used for analysis. The “training-set”
consisted of 79 images of full or partial bones. The “validation-
set” consisted of 59 images of full bones. Parameters are pre-set
but adjustable by the user if deemed necessary (e.g., adipocyte
circularity or size, see tutorial for details). The software workflow
follows basic morphological operations, color deconvolutions,
thresholding, smoothing operations, and watershed as annotated
in the code provided as open source and described in the
technical guidelines. When accounting for pre-processing steps
such as the drawing of the regions of interests as well the as
the segmentation process, it typically takes 1–2min in order to
obtain MarrowQuant outputs for an image with a sample of a
mouse bone. Technical details are annotated in the code and
details on download, installation and use of the plugin with
the QuPath software are given in the tutorial (MarrowQuant
Tutorial, Supplementary Material).
MicroCT
Fixed bones were scanned for reconstruction of undecalcified
bone. Samples were placed in an Eppendorf tube with PBS and
scanned using a Quantum X-Ray Micro-CT Scanner (Perkin
Elmer Quantum) at 90 kV, 160 µA, CT 160, live 80, and field
of view (voxel size) 20 µm2 at setting “Fine” for 2min per
sample. A hydroxyapatite phantom was included as control.
The software suite provided by the manufacturer was used
for image acquisition and reconstruction. Bones were then
processed further with formic acid decalcification and osmium
tetroxide staining.
Osmium Tetroxide Staining
Decalcified bones were rinsed in distilled water. Osmium
tetroxide solution was prepared fresh (1% osmium tetroxide
[Electron Microscopy Sciences 19110), 2.5% dichromate
potassium solution (VWR 1.04864.0500)] with appropriate
chemical safety protection and samples stained in 20ml glass
scintillation vials (Electron Microscopy Sciences 7632) in 2ml of
solution at room temperature for 48 h. Bones were washed with
distilled water three times and transferred to Eppendorf tubes
with distilled water for µCT acquisition as done previously.
Quantifications were done on the Analyzer 10.0 software
(Analyze Direct, Inc.).
Statistical Analysis
Values are shown as mean plus or minus the standard deviation.
Statistical analysis was performed usingGraphPad Prism (version
8.0.0, GraphPad Software) or R Statistical Analysis Software
(2013, R Core Team). Mean values were compared by Student’s
t-test or two-way analysis of variance (ANOVA). Statistical
significance was accepted for P < 0.05, and reported.
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